株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

dPCR、qPCR市場:世界市場分析と予測:技術別(デジタルPCR、定量的PCR)、製品別、用途別、地域別

dPCR and qPCR Market to 2025 - Global Analysis and Forecasts by Technology (Digital PCR and Quantitative PCR ); Product ; Application and Geography

発行 The Insight Partners 商品コード 755828
出版日 ページ情報 英文 159 Pages
即納可能
価格
本日の銀行送金レート: 1USD=109.13円で換算しております。
Back to Top
dPCR、qPCR市場:世界市場分析と予測:技術別(デジタルPCR、定量的PCR)、製品別、用途別、地域別 dPCR and qPCR Market to 2025 - Global Analysis and Forecasts by Technology (Digital PCR and Quantitative PCR ); Product ; Application and Geography
出版日: 2018年11月26日 ページ情報: 英文 159 Pages
概要

当レポートでは、世界のdPCR、qPCR市場について調査し、市場の動向とセグメント別概要、地域別動向、および市場に参入主要企業のプロファイルと競合動向についてまとめています。

第1章 イントロダクション

第2章 概要

第3章 市況

  • 概要
  • 市場セグメンテーション
  • PEST分析

第4章 主な市場動向

  • 市場促進因子
  • 市場阻害因子
  • 市場の機会
  • 将来動向
  • 影響分析

第5章 世界市場分析

  • 市場収益予測と分析
  • 地域別市場
  • 市場ポジショニング
  • 主要参入企業の実績
  • 専門家の見解

第6章 技術別市場

  • 概要
  • デジタルPCR
  • 定量的PCR

第7章 製品別市場

  • 概要
  • 試薬・消耗品
  • 計器
  • ソフトウェア・サービス

第8章 用途別市場

  • 概要
  • 臨床
  • 研究
  • 法医学

第9章 北米市場

第10章 欧州市場

第11章 アジア太平洋地域市場

第12章 中東・アフリカ市場

第13章 中南米市場

第14章 業界環境

  • 概要
  • 成長戦略
  • 有機的成長戦略
  • 無機的成長戦略

第15章 企業プロファイル

  • ABBOTT
  • F. HOFFMANN-LA ROCHE LTD.
  • THERMO FISHER SCIENTIFIC, INC.
  • BIO-RAD LABORATORIES, INC.
  • QIAGEN
  • タカラバイオ株式会社
  • AGILENT TECHNOLOGIES, INC.
  • BIOMERIEUX SA
  • DANAHER
  • FLUIDIGM CORPORATION

第16章 付録

目次
Product Code: TIPHE100000817

In the report the dPCR and qPCR market, the market is expected to reach US$ 6,371.6 Mn in 2025 from US$ 3,255.5 in 2017. The market is estimated to grow with a CAGR of 9.1% from 2017-2025.

The dPCR and qPCR market is driven by the driving factor such as increasing incidence of genetic diseases, growth in investments & funds for dPCR and qPCR techniques and gene synthesis, increasing number of start-up companies and technological developments in PCR technologies are likely to drive the market in the coming years. The market is likely to restrain its growth due to the factors such as technical limitations associated with qPCR and high cost of PCR systems. Whereas the increasing trend of developing droplet digital PCR for various applications are likely to propel the growth of the market.

The dPCR and qPCR market as per the technology the segment is segmented as Digital PCR (dPCR) and Qualitative PCR (qPCR). The market of qPCR has the highest market share in 2017, contributing a market share of 55.9% and is expected to retain its dominance during the forecast period from 2018 to 2025. The higher acceptance of the qPCR procedure for the molecular diagnostics and research are likely to propel the dPCR and qPCR market in the coming future. Likewise the dPCR contributed 44.1% of the market share in the year 2017 and is expected to be the fastest growing market in the coming near future.

The product segment of the dPCR and qPCR market includes reagents & consumables, instruments, and software and services. The reagents & consumables segment for the dPCR and qPCR market was valued at US$ 1,515.4 Mn in 2017 and is estimated to grow at a CAGR of 9.3% during the forecast period from 2017 to 2025, to reach US$ 3,015.0 Mn by 2025. The reagents & consumables segments is likely to dominate the market in the coming future as they are the basic requirement of researchers or healthcare professionals to conduct diagnosis or research. The software and services segments are the fastest growing segment in the product as these are extensively used for the dPCR and qPCR projects. The segment is expected to be the fastest growing segment in the forecast period.

Some of the major primary and secondary sources included in the report dPCR and qPCR market are Biotechnology Innovation Organization (BIO), Collaborative Research Programme (CRP Synthetic Biology Leadership Council, Industrial Biotechnology Leadership Forum (IBLF), Centers for Disease Control and Prevention, Department of Biotechnology, Postillion Convention Centre WTC, National Center for Biotechnology Information, Institute of Chemical Biology, National Reference Laboratory (NRL), World Health Organization, European Union, Food and Drug Administration and more.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the dPCR and qPCR market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global dPCR and qPCR market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution

TABLES OF CONTENTS

1. INTRODUCTION 21

  • 1.1 SCOPE OF THE STUDY 21
  • 1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE 21

2. GLOBAL DPCR AND QPCR MARKET - KEY TAKEAWAYS 22

3. GLOBAL DPCR AND QPCR MARKET - MARKET LANDSCAPE 25

  • 3.1 OVERVIEW 25
  • 3.2 MARKET SEGMENTATION 25
    • 3.2.1 Global Dpcr and Qpcr market - By Technology 26
    • 3.2.2 Global Dpcr and Qpcr market - By Product 26
    • 3.2.3 Global Dpcr and Qpcr market - By Application 26
    • 3.2.4 Global Dpcr and Qpcr market - By Geography 26
  • 3.4 PEST ANALYSIS 28
    • 3.4.1 North America - PEST Analysis 28
    • 3.4.2 Europe- PEST Analysis 30
    • 3.4.3 Asia Pacific - PEST Analysis 32
    • 3.4.4 Middle East & Africa - PEST Analysis 34
    • 3.4.5 South & Central America - PEST Analysis 36

4. GLOBAL DPCR AND QPCR MARKET - KEY MARKET DYNAMICS 38

  • 4.1 KEY MARKET DRIVERS 38
    • 4.1.1 Increasing Incidence of Genetic Diseases 38
    • 4.1.2 Increase in Investments & Funds for Gene Synthesis 38
    • 4.1.3 Technological Advancements in PCR Technologies 39
  • 4.2 KEY MARKET RESTRAINTS 40
    • 4.2.1 High Costs of PCR Systems 40
    • 4.2.2 Technical Limitations Associated with Qpcr 40
  • 4.3 KEY MARKET OPPORTUNITIES 41
    • 4.3.1 Growing adoption of PCR methods in Emerging countries 41
  • 4.4 FUTURE TRENDS 41
    • 4.4.1 Development of Droplet Digital PCR (ddPCR). 41
  • 4.5 IMPACT ANALYSIS 42

5. DPCR AND QPCR MARKET - GLOBAL ANALYSIS 43

  • 5.1 GLOBAL DPCR AND QPCR MARKET REVENUE FORECASTS AND ANALYSIS 43
  • 5.2 GLOBAL DPCR AND QPCR MARKET, BY GEOGRAPHY - FORECASTS AND ANALYSIS 44
  • 5.3 MARKET POSITIONING 45
  • 5.4 PERFORMANCE OF KEY PLAYERS 45
    • 5.4.1 Thermo Fisher Scientific, Inc. 45
    • 5.4.2 F. Hoffmann-La Roche Ltd 45
  • 5.5 EXPERT OPINIONS 46

6. GLOBAL DPCR AND QPCR MARKET ANALYSIS - BY TECHNOLOGY 47

  • 6.1 OVERVIEW 47
  • 6.2 DIGITAL PCR (DPCR) MARKET 48
    • 6.2.1 Overview 48
    • 6.2.2 Global Digital PCR (Dpcr) Market Revenue and Forecasts to 2025 (US$ Mn) 48
  • 6.3 QUANTITATIVE PCR (QPCR) MARKET 49
    • 6.3.1 Overview 49
    • 6.3.2 Global Quantitative PCR (Qpcr) Market Revenue and Forecasts to 2025 (US$ Mn) 49

7. GLOBAL DPCR AND QPCR MARKET ANALYSIS - BY PRODUCT 50

  • 7.1 OVERVIEW 50
  • 7.2 REAGENTS & CONSUMABLES MARKET 50
    • 7.2.1 Overview 50
    • 7.2.2 Global Reagents and Consumables Market Revenue and Forecasts to 2025 (US$ Mn) 51
  • 7.3 INSTRUMENTS MARKET 52
    • 7.3.1 Overview 52
    • 7.3.2 Global Instruments Market Revenue and Forecasts to 2025 (US$ Mn) 52
  • 7.4 SOFTWARE & SERVICES MARKET 53
    • 7.4.1 Overview 53
    • 7.4.2 Global Software & Services Market Revenue and Forecasts to 2025 (US$ Mn) 53

8. GLOBAL DPCR AND QPCR MARKET ANALYSIS- BY APPLICATION 54

  • 8.1 OVERVIEW 54
  • 8.2 GLOBAL DPCR AND QPCR MARKET, BY APPLICATION 2017 & 2025 (%) 54
    • 8.2.1 Clinical Application Market 54
      • 8.2.1.1 Overview 54
      • 8.2.1.2 Global Clinical Application Market Revenue And Forecasts To 2025 (US$ Mn) 54
      • 8.2.1.3 Pathogen Testing Market 56
        • 8.2.1.3.1 Overview 56
        • 8.2.1.3.2 Global Pathogen Testing Market Revenue And Forecasts To 2025 (US$ Mn) 56
      • 8.2.1.4 Oncology Testing Market 57
        • 8.2.1.4.1 Overview 57
        • 8.2.1.4.2 Global Oncology Testing Market Revenue And Forecasts To 2025 (US$ Mn) 57
      • 8.2.1.5 Blood Screening Testing Market 57
        • 8.2.1.5.1 Overview 57
        • 8.2.1.5.2 Global Blood Screening Testing Market Revenue And Forecasts To 2025 (US$ Mn) 58
    • 8.2.2 Research Application Market 58
      • 8.2.2.1 Overview 58
      • 8.2.2.2 Global Research Application Market Revenue And Forecasts To 2025 (US$ Mn) 58
    • 8.2.3 Forensic Application Market 59
      • 8.2.3.1 Overview 59
      • 8.2.3.2 Global Forensic Application Market Revenue And Forecasts To 2025 (US$ Mn) 59

9. NORTH AMERICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 61

  • 9.1 OVERVIEW 61
  • 9.2 NORTH AMERICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 62
  • 9.3 NORTH AMERICA DPCR AND QPCR MARKET REVENUE AND FORECASTS, BY TECHNOLOGY (US$ MN) 62
    • 9.3.1 North America Dpcr and Qpcr Market Revenue And Forecasts to 2025, By Product (US$ Mn) 62
    • 9.3.2 North america Dpcr and Qpcr Market Revenue And Forecasts to 2025, By Application (US$ Mn) 62
    • 9.3.3 North america Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 63
  • 9.4 NORTH AMERICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 63
  • 9.5 US DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 64
    • 9.5.1 US Dpcr and Qpcr Market Revenue and Forecasts to 2025 (US$ Mn) 65
    • 9.5.2 US Dpcr and Qpcr Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 65
    • 9.5.3 US Dpcr and Qpcr market Revenue And Forecasts to 2025, By Product (US$ Mn) 65
    • 9.5.4 US Dpcr and Qpcr Market Revenue And Forecasts to 2025, By Application (US$ Mn) 66
    • 9.5.5 US Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 66
  • 9.6 CANADA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 67
    • 9.6.1 Canada Dpcr and Qpcr market Revenue and Forecasts to 2025 (US$ Mn) 67
    • 9.6.2 Canada Dpcr and Qpcr Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 68
    • 9.6.3 Canada Dpcr and Qpcr Market Revenue And Forecasts to 2025, By Product (US$ Mn) 68
    • 9.6.4 Canada Dpcr and Qpcr Market Revenue And Forecasts to 2025, By Application (US$ Mn) 68
    • 9.6.5 Canada Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 69
  • 9.7 MEXICO DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 70
    • 9.7.1 Mexico DPCR and Qpcr market Revenue and Forecasts to 2025 (US$ Mn) 70
    • 9.7.2 Mexico Dpcr and Qpcr Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 71
    • 9.7.3 Mexico Dpcr and Qpcr Market Revenue And Forecasts to 2025, By Product (US$ Mn) 71
    • 9.7.4 Mexico Dpcr and Qpcr Market Revenue And Forecasts to 2025, By Application (US$ Mn) 71
    • 9.7.5 Mexico Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 72

10. EUROPE DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 73

  • 10.1 OVERVIEW 73
  • 10.2 EUROPE DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 74
  • 10.3 EUROPE DPCR AND QPCR MARKET REVENUE AND FORECASTS, BY TECHNOLOGY (US$ MN) 74
    • 10.3.1 Europe Dpcr and Qpcr Market Revenue And Forecasts to 2025, By Product (US$ Mn) 74
    • 10.3.2 Europe Dpcr and Qpcr Market Revenue And Forecasts to 2025, By Application (US$ Mn) 74
    • 10.3.3 Europe Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 75
  • 10.4 EUROPE DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 75
  • 10.5 UK DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 76
    • 10.5.1 UK Dpcr and Qpcr market Revenue and Forecasts to 2025 (US$ Mn) 77
    • 10.5.2 UK Dpcr and Qpcr Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 77
    • 10.5.3 UK Dpcr and Qpcr market Revenue And Forecasts to 2025, By Product (US$ Mn) 77
    • 10.5.4 UK Dpcr and Qpcr Market Revenue And Forecasts to 2025, By Application (US$ Mn) 78
    • 10.5.5 UK Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 78
  • 10.6 GERMANY DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 79
    • 10.6.1 Germany Dpcr and Qpcr market Revenue and Forecasts to 2025 (US$ Mn) 80
    • 10.6.2 Germany Dpcr and Qpcr Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 80
    • 10.6.3 Germany Dpcr and Qpcr Market Revenue And Forecasts to 2025, By Product (US$ Mn) 80
    • 10.6.4 Germany Dpcr and Qpcr Market Revenue And Forecasts to 2025, By Application (US$ Mn) 81
    • 10.6.5 Germany Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 81
  • 10.7 FRANCE DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 82
    • 10.7.1 France Dpcr and Qpcr market Revenue and Forecasts to 2025 (US$ Mn) 83
    • 10.7.2 France Dpcr and Qpcr Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 83
    • 10.7.3 France Dpcr and Qpcr Market Revenue And Forecasts to 2025, By Product (US$ Mn) 83
    • 10.7.4 France Dpcr and Qpcr Market Revenue And Forecasts to 2025, By Application (US$ Mn) 84
    • 10.7.5 France Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 84

11. ASIA PACIFIC DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 85

  • 11.1 OVERVIEW 85
  • 11.2 ASIA PACIFIC DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 86
  • 11.3 ASIA PACIFIC DPCR AND QPCR MARKET REVENUE AND FORECASTS, BY TECHNOLOGY (US$ MN) 86
    • 11.3.1 Asia Pacific Dpcr and Qpcr Market Revenue And Forecasts to 2025, By Product (US$ Mn) 86
    • 11.3.2 Asia Pacific Dpcr and Qpcr Market Revenue And Forecasts to 2025, By Application (US$ Mn) 86
    • 11.3.3 Asia Pacific Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 87
  • 11.4 ASIA PACIFIC DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 87
  • 11.5 CHINA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 88
    • 11.5.1 China Dpcr and Qpcr market Revenue and Forecasts to 2025 (US$ Mn) 88
  • 11.6 CHINA DPCR AND QPCR MARKET REVENUE AND FORECASTS, BY TECHNOLOGY (US$ MN) 88
    • 11.6.1 China Dpcr and Qpcr Market Revenue And Forecasts to 2025, By Product (US$ Mn) 89
    • 11.6.2 China Dpcr and Qpcr Market Revenue And Forecasts to 2025, By Application (US$ Mn) 89
    • 11.6.3 China Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 89
  • 11.7 JAPAN DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 89
    • 11.7.1 Japan Dpcr and Qpcr market Revenue and Forecasts to 2025 (US$ Mn) 90
  • 11.8 JAPAN DPCR AND QPCR MARKET REVENUE AND FORECASTS, BY TECHNOLOGY (US$ MN) 90
    • 11.8.1 Japan Dpcr and Qpcr Market Revenue And Forecasts to 2025, By Product (US$ Mn) 90
    • 11.8.2 Japan Dpcr and Qpcr Market Revenue And Forecasts to 2025, By Application (US$ Mn) 91
    • 11.8.3 Japan Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 91
  • 11.9 INDIA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 92
    • 11.9.1 India Dpcr and Qpcr market Revenue and Forecasts to 2025 (US$ Mn) 92
  • 11.10 INDIA DPCR AND QPCR MARKET REVENUE AND FORECASTS, BY TECHNOLOGY (US$ MN) 92
    • 11.10.1 India Dpcr and Qpcr Market Revenue And Forecasts to 2025, By Product (US$ Mn) 93
    • 11.10.2 India Dpcr and Qpcr Market Revenue And Forecasts to 2025, By Application (US$ Mn) 93
    • 11.10.3 India Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 93

12. MIDDLE EAST AND AFRICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 94

  • 12.1 OVERVIEW 94
  • 12.2 MIDDLE EAST AND AFRICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 95
  • 12.3 MIDDLE EAST AND AFRICA DPCR AND QPCR MARKET REVENUE AND FORECASTS, BY TECHNOLOGY (US$ MN) 95
    • 12.3.1 Middle East and Africa Dpcr and Qpcr Market Revenue And Forecasts to 2025, By Product (US$ Mn) 95
    • 12.3.2 Middle East and Africa Dpcr and Qpcr Market Revenue And Forecasts to 2025, By Application (US$ Mn) 96
    • 12.3.3 Middle East and Africa Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 96
  • 12.4 MIDDLE EAST AND AFRICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 96
  • 12.6 UAE DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 98
    • 12.6.1 UAE Dpcr and Qpcr market Revenue and Forecasts to 2025 (US$ Mn) 98
  • 12.7 UAE DPCR AND QPCR MARKET REVENUE AND FORECASTS, BY TECHNOLOGY (US$ MN) 98
    • 12.7.1 UAE Dpcr and Qpcr Market Revenue And Forecasts to 2025, By Product (US$ Mn) 99
    • 12.7.2 UAE Dpcr and Qpcr Market Revenue And Forecasts to 2025, By Application (US$ Mn) 99
    • 12.7.3 UAE Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 99
  • 12.8 SAUDI ARABIA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 99
    • 12.8.1 Saudi Arabia Dpcr and Qpcr market Revenue and Forecasts to 2025 (US$ Mn) 100
  • 12.9 SAUDI ARABIA DPCR AND QPCR MARKET REVENUE AND FORECASTS, BY TECHNOLOGY (US$ MN) 100
    • 12.9.1 Saudi Arabia Dpcr and Qpcr Market Revenue And Forecasts to 2025, By Product (US$ Mn) 101
    • 12.9.2 Saudi Arabia Dpcr and Qpcr Market Revenue And Forecasts to 2025, By Application (US$ Mn) 101
    • 12.9.3 Saudi Arabia Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 101
  • 12.10 SOUTH AFRICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 101
    • 12.10.1 South Africa Dpcr and Qpcr market Revenue and Forecasts to 2025 (US$ Mn) 102
  • 12.11 SOUTH AFRICA DPCR AND QPCR MARKET REVENUE AND FORECASTS, BY TECHNOLOGY (US$ MN) 102
    • 12.11.1 South Africa Dpcr and Qpcr Market Revenue And Forecasts to 2025, By Product (US$ Mn) 103
    • 12.11.2 South Africa Dpcr and Qpcr Market Revenue And Forecasts to 2025, By Application (US$ Mn) 103
    • 12.11.3 South Africa Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 103

13. SOUTH AND CENTRAL AMERICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 104

  • 13.1 OVERVIEW 104
  • 13.2 SOUTH AND CENTRAL AMERICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 105
  • 13.3 SOUTH AND CENTRAL AMERICA DPCR AND QPCR MARKET REVENUE AND FORECASTS, BY TECHNOLOGY (US$ MN) 105
    • 13.3.1 South and Central America Dpcr and Qpcr Market Revenue And Forecasts to 2025, By Product (US$ Mn) 105
    • 13.3.2 South and Central America Dpcr and Qpcr Market Revenue And Forecasts to 2025, By Application (US$ Mn) 106
    • 13.3.3 South and Central America Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 106
  • 13.4 SOUTH AND CENTRAL AMERICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 106
  • 13.5 BRAZIL DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 107
    • 13.5.1 Brazil Dpcr and Qpcr market Revenue and Forecasts to 2025 (US$ Mn) 107
  • 13.6 BRAZIL DPCR AND QPCR MARKET REVENUE AND FORECASTS, BY TECHNOLOGY (US$ MN) 107
    • 13.6.1 Brazil Dpcr and Qpcr Market Revenue And Forecasts to 2025, By Product (US$ Mn) 108
    • 13.6.2 Brazil Dpcr and Qpcr Market Revenue And Forecasts to 2025, By Application (US$ Mn) 108
    • 13.6.3 Brazil Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 108

14. DPCR AND QPCR MARKET -KEY COMPANY PROFILES 110

  • 14.1 ABBOTT 110
    • 14.1.1 Key Facts 110
    • 14.1.2 Business Description 110
    • 14.1.3 Financial Information 111
    • 14.1.4 Product Portfolio 111
    • 14.1.5 SWOT Analysis 111
    • 14.1.6 Key Developments 113
  • 14.2 F. HOFFMANN-LA ROCHE LTD. 114
    • 14.2.1 Key Facts 114
    • 14.2.2 Business Description 114
    • 14.2.3 Financial Overview 115
    • 14.2.4 Product Portfolio 115
    • 14.2.5 Swot Analysis 116
    • 14.2.6 Key Developments 117
  • 14.3 THERMO FISHER SCIENTIFIC, INC. 118
    • 14.3.1 Key Facts 118
    • 14.3.2 Business Description 118
    • 14.3.3 Financial Information 119
    • 14.3.4 Product Portfolio 119
    • 14.3.5 SWOT Analysis 120
    • 14.3.6 Key Developments 121
  • 14.4 BIO-RAD LABORATORIES, INC. 122
    • 14.4.1 Key Facts 122
    • 14.4.2 Business Description 122
    • 14.4.3 Financial Information 123
    • 14.4.4 Product Portfolio 123
    • 14.4.5 SWOT Analysis 123
    • 14.4.6 Key Developments 124
  • 14.5 QIAGEN 126
    • 14.5.1 Key Facts 126
    • 14.5.2 Business Description 126
    • 14.5.3 Financial Overview 126
    • 14.5.4 Product Portfolio 127
    • 14.5.5 Swot Analysis 128
    • 14.5.6 Key Developments 129
  • 14.6 TAKARA BIO, INC. 130
    • 14.6.1 Key Facts 130
    • 14.6.2 Business Description 130
    • 14.6.3 Financial Information 131
    • 14.6.4 Product Portfolio 131
    • 14.6.5 SWOT Analysis 132
    • 14.6.6 Key Developments 133
  • 14.7 AGILENT TECHNOLOGIES, INC. 135
    • 14.7.1 Key Facts 135
    • 14.7.2 Business Description 135
    • 14.7.3 Financial Information 136
    • 14.7.4 Product Portfolio 136
    • 14.7.5 SWOT Analysis 137
    • 14.7.6 Key Developments 138
  • 14.8 BIOMERIEUX SA 139
    • 14.8.1 Key Facts 139
    • 14.8.2 Business Description 139
    • 14.8.3 Financial Information 140
    • 14.8.4 Product Portfolio 140
    • 14.8.5 SWOT Analysis 141
    • 14.8.6 Key Developments 142
  • 14.9 DANAHER 143
    • 14.9.1 Key Facts 143
    • 14.9.2 Business Description 143
    • 14.9.3 Financial Overview 143
    • 14.9.4 Product Portfolio 144
    • 14.9.5 Swot Analysis 144
    • 14.9.6 Key Developments 146
  • 14.10 FLUIDIGM CORPORATION 147
    • 14.10.1 Key Facts 147
    • 14.10.2 Business Description 147
    • 14.10.3 Financial Overview 148
    • 14.10.4 Product Portfolio 148
    • 14.10.5 Swot Analysis 149
    • 14.10.6 Key Developments 150

15. APPENDIX 152

  • 15.1 ABOUT THE INSIGHT PARTNERS 152
  • 15.2 GLOSSARY OF TERMS 153
  • 15.3 METHODOLOGY 156
    • 15.3.1 Coverage 157
    • 15.3.2 Secondary Research 158
    • 15.3.3 Primary Research 158

LIST OF TABLES

  • TABLE 1. NORTH AMERICA AND AFRICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 63
  • TABLE 2. NORTH AMERICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 63
  • TABLE 3. NORTH AMERICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 64
  • TABLE 4. NORTH AMERICA AND AFRICA CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 64
  • TABLE 5. US DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 66
  • TABLE 6. US DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 66
  • TABLE 7. US DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 67
  • TABLE 8. US CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 67
  • TABLE 9. CANADA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 69
  • TABLE 10. CANADA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 69
  • TABLE 11. CANADA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 69
  • TABLE 12. CANADA CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 70
  • TABLE 13. MEXICO DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 72
  • TABLE 14. MEXICO DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 72
  • TABLE 15. MEXICO DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 72
  • TABLE 16. MEXICO CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 73
  • TABLE 17. EUROPE DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 75
  • TABLE 18. EUROPE DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 75
  • TABLE 19. EUROPE DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 76
  • TABLE 20. EUROPE CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 76
  • TABLE 21. UK DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 78
  • TABLE 22. UK DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 78
  • TABLE 23. UK DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 79
  • TABLE 24. UK CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 79
  • TABLE 25. GERMANY DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 81
  • TABLE 26. GERMANY DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 81
  • TABLE 27. GERMANY DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 82
  • TABLE 28. GERMANY CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 82
  • TABLE 29. FRANCE DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 84
  • TABLE 30. FRANCE DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 84
  • TABLE 31. FRANCE DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 85
  • TABLE 32. FRANCE CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 85
  • TABLE 33. ASIA PACIFIC DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 87
  • TABLE 34. ASIA PACIFIC DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 87
  • TABLE 35. ASIA PACIFIC DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 88
  • TABLE 36. ASIA PACIFIC CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 88
  • TABLE 37. CHINA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 89
  • TABLE 38. CHINA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 90
  • TABLE 39. CHINA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 90
  • TABLE 40. CHINA CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 90
  • TABLE 41. JAPAN DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 91
  • TABLE 42. JAPAN DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 92
  • TABLE 43. JAPAN DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 92
  • TABLE 44. JAPAN CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 92
  • TABLE 45. INDIA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 93
  • TABLE 46. INDIA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 94
  • TABLE 47. INDIA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 94
  • TABLE 48. INDIA CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 94
  • TABLE 49. MIDDLE EAST AND AFRICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 96
  • TABLE 50. MIDDLE EAST AND AFRICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 96
  • TABLE 51. MIDDLE EAST AND AFRICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 97
  • TABLE 52. MIDDLE EAST AND AFRICA CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 97
  • TABLE 53. UAE DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 99
  • TABLE 54. UAE DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 100
  • TABLE 55. UAE DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 100
  • TABLE 56. UAE CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 100
  • TABLE 57. SAUDI ARABIA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 101
  • TABLE 58. SAUDI ARABIA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 102
  • TABLE 59. SAUDI ARABIA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 102
  • TABLE 60. SAUDI ARABIA CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 102
  • TABLE 61. SOUTH AFRICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 103
  • TABLE 62. SOUTH AFRICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 104
  • TABLE 63. SOUTH AFRICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 104
  • TABLE 64. SOUTH AFRICA CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 104
  • TABLE 65. SOUTH AND CENTRAL AMERICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 106
  • TABLE 66. SOUTH AND CENTRAL AMERICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 106
  • TABLE 67. SOUTH AND CENTRAL AMERICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 107
  • TABLE 68. SOUTH AND CENTRAL AMERICA CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 107
  • TABLE 69. BRAZIL DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 109
  • TABLE 70. BRAZIL DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 109
  • TABLE 71. BRAZIL DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 109
  • TABLE 72. BRAZIL CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 109
  • TABLE 73. GLOSSARY OF TERMS, DPCR AND QPCR MARKET 154

LIST OF FIGURES

  • FIGURE 1. ASIA PACIFIC DPCR AND QPCR MARKET, REVENUE (US$ MN), BY GEOGRAPHY 2018 & 2025 23
  • FIGURE 2. GLOBAL DPCR AND QPCR MARKET BY TECHNOLOGY, MARKET SHARE (%), 2017 24
  • FIGURE 3. GLOBAL DPCR AND QPCR MARKET BY APPLICATION, MARKET SHARE (%), 2017 24
  • FIGURE 4. GLOBAL DPCR AND QPCR MARKET BY APPLICATION, MARKET SHARE (%), 2017 24
  • FIGURE 5. DPCR AND QPCR MARKET SEGMENTATION 26
  • FIGURE 6. DPCR AND QPCR SEGMENTATION, BY REGION 27
  • FIGURE 7. NORTH AMERICA PEST ANALYSIS 29
  • FIGURE 8. EUROPE PEST ANALYSIS 31
  • FIGURE 9. ASIA PACIFIC PEST ANALYSIS 33
  • FIGURE 10. MIDDLE EAST & AFRICA PEST ANALYSIS 35
  • FIGURE 11. SOUTH & CENTRAL AMERICA PEST ANALYSIS 37
  • FIGURE 12. DPCR AND QPCR MARKET IMPACT ANALYSIS OF DRIVER AND RESTRAINTS 43
  • FIGURE 13. GLOBAL DPCR AND QPCR MARKET - REVENUE FORECASTS AND ANALYSIS - 2016- 2025 44
  • FIGURE 14. GLOBAL DPCR AND QPCR MARKET - BY GEOGRAPHY FORECASTS AND ANALYSIS - 2017- 2025 45
  • FIGURE 15. GLOBAL DPCR AND QPCR MARKET - MARKET POSITIONING, 2017 46
  • FIGURE 16. GLOBAL DPCR AND QPCR MARKET BREAKDOWN BY TECHNOLOGY, 2017 & 2025 (%) 48
  • FIGURE 17. GLOBAL DIGITAL PCR (DPCR) MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 49
  • FIGURE 18. GLOBAL QUANTITATIVE PCR (QPCR) MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 50
  • FIGURE 19. GLOBAL DPCR AND QPCR MARKET BREAKDOWN BY PRODUCT, 2017 & 2025 (%) 51
  • FIGURE 20. GLOBAL REAGENTS AND CONSUMABLES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 52
  • FIGURE 21. GLOBAL INSTRUMENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 53
  • FIGURE 22. GLOBAL SOFTWARE & SERVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 54
  • FIGURE 23. GLOBAL DPCR AND QPCR MARKET, BY APPLICATION 2017 & 2025 (%) 55
  • FIGURE 24. GLOBAL CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 56
  • FIGURE 25. GLOBAL PATHOGEN TESTING MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 57
  • FIGURE 26. GLOBAL ONCOLOGY TESTING MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 58
  • FIGURE 27. GLOBAL BLOOD SCREENING TESTING MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 59
  • FIGURE 28. GLOBAL RESEARCH APPLICATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 59
  • FIGURE 29. GLOBAL FORENSIC APPLICATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 60
  • FIGURE 30. NORTH AMERICA DPCR AND QPCR MARKET REVENUE, BY COUNTRY, 2017 (US$ MN) 62
  • FIGURE 31. NORTH AMERICA MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 63
  • FIGURE 32. NORTH AMERICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 64
  • FIGURE 33. US DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 66
  • FIGURE 34. CANADA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 68
  • FIGURE 35. MEXICO DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 71
  • FIGURE 36. EUROPE DPCR AND QPCR MARKET REVENUE, BY COUNTRY, 2017 (US$ MN) 74
  • FIGURE 37. EUROPE MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 75
  • FIGURE 38. EUROPE DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 76
  • FIGURE 39. UK DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 78
  • FIGURE 40. GERMANY DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 81
  • FIGURE 41. FRANCE DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 84
  • FIGURE 42. ASIA PACIFIC DPCR AND QPCR MARKET REVENUE, BY COUNTRY, 2017 (US$ MN) 86
  • FIGURE 43. ASIA PACIFIC MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 87
  • FIGURE 44. ASIA PACIFIC DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 88
  • FIGURE 45. CHINA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 89
  • FIGURE 46. JAPAN DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 91
  • FIGURE 47. INDIA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 93
  • FIGURE 48. MIDDLE EAST AND AFRICA DPCR AND QPCR MARKET REVENUE, BY COUNTRY, 2017 (US$ MN) 95
  • FIGURE 49. MIDDLE EAST AND AFRICA MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 96
  • FIGURE 50. MIDDLE EAST AND AFRICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 97
  • FIGURE 51. UAE DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 99
  • FIGURE 52. SAUDI ARABIA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 101
  • FIGURE 53. SOUTH AFRICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 103
  • FIGURE 54. SOUTH AND CENTRAL AMERICA DPCR AND QPCR MARKET REVENUE, BY COUNTRY, 2017 (US$ MN) 105
  • FIGURE 55. SOUTH AND CENTRAL AMERICA MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 106
  • FIGURE 56. SOUTH AND CENTRAL AMERICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 107
  • FIGURE 57. BRAZIL DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 108
Back to Top